PRTA

8.1403.10%
RT

Richard T. Collier

Independent Director

Mr. Richard T. Collier, Esq., JD served as an Executive Vice President of Elan Corporation, plc since November 30, 2004 until 2010 and served as its Senior Advisor. Mr. Collier served as General Counsel of Elan Corp. plc since November 30, 2004 until 2010. Mr. Collier has overall responsibility for Elan's legal organization and is an integral part of its leadership team. He has been a Special Counsel of Life Sciences Practice Group at Morgan, Lewis & Bockius LLP since October 2003. He served as a Senior Vice President and General Counsel of Pharmacia Corporation since March 2000. Prior to joining Morgan Lewis, Mr. Collier served as Senior Vice President and General Counsel of Pharmacia & Upjohn, LLC/Inc. (P&U), (now Pfizer) a subsidiary of Pharmacia Corp., from December 1997 to March 2000. He served as Senior Vice President and General Counsel of Aventis Inc., since January 1995 and served as its Vice President and General Counsel, U.S. since October 1992. He served as Senior Vice President, General Counsel and a Member of the Executive Council of Rhone-Poulenc Rorer Inc., from December 1994 to December 1997. He joined Rhone-Poulenc Rorer in 1986 as Assistant Counsel and held various positions including Vice President and Assistant to the Chairman from 1991 to 1992. Prior to Pharmacia, he spent 11 years at Rhone-Poulenc Rorer, Inc. Mr. Collier was in private practice after he served with the U.S. Federal Trade Commission and U.S. Department of Justice. He has been an Independent Director at Prothena Corporation plc since December 2012. He holds B.A. of Temple University and also earned his Juris Doctor in Law at Temple University. Mr. Collier was an Adjunct Professor of Law at the Temple University Beasley School of Law, where he taught drug and medical device law from 2004 to 2017. He also practiced law at two leading Philadelphia-based law firms and with the U.S. Federal Trade Commission and U.S. Department of Justice.

公司職務